Effects of glucagon-like peptide-1 receptor agonists on glucose excursion and inflammation in overweight or obese type 2 diabetic patients

Figure 2 Changes in blood glucose level and islet cell function of patients before and after treatment. A: 24-h mean blood glucose (MBG); B: 24-h standard deviation of blood glucose (SDBG); C: Coefficient of variation (CV%); D: Mean amplitude of glycemic excursions (MAGEs); E: Absolute mean of daily differences (MODD); F: Percentage of time (TIR) with 3.9 mmol/L < glucose < 10 mmol/L before and after treatment in the two groups. ^aP < 0.001.